
Alnylam Pharmaceuticals to Appeal Patent Ruling Over Moderna’s COVID Vaccine Technology
August 26, 2023
Alnylam Pharmaceuticals has announced its intention to challenge a recent decision from the U.S. District Court in Delaware regarding two patents that were brought into question in relation to Moderna’s COVID-19 vaccine, Spikevax. Alnylam, headquartered in Cambridge, Massachusetts, had previously






